Home > GAO Report: Oversight of the Intersection with the Medicaid Drug Rebate Program Needs Improvement
Posted January 1, 2020
GAO Report: Oversight of the Intersection with the Medicaid Drug Rebate Program Needs Improvement
Under the 340B Drug Pricing Program (340B Program), administered by the U.S. Department of Health and Human Services’ (HHS) Health Resources and Services Administration (HRSA), drug manufacturers provide discounted prices on outpatient drugs to certain hospitals and other entities.